SAMURAI
LIVE

Serial Number

97746884

Owner

Seqirus Inc.

Attorney

Nancy Sabarra

Filing Date

Jan 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SAMURAI Trademark

Serial Number: 97746884

SAMURAI is a trademark filed by Seqirus Inc. on January 9, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Seqirus Inc. (84 trademarks)

475 Green Oaks Parkway
Holly Springs, NC 27540

Entity Type: 03

Trademark Details

Filing Date

January 9, 2023

Registration Date

Not Registered

Published for Opposition

April 23, 2024

Goods & Services

Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells

Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Medical services; medical information; providing a website featuring medical information

Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, namely, for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 22, 2026 EXRA
SOU EXTENSION 4 GRANTED
May 21, 2026 EX4G
SOU EXTENSION 4 FILED
May 21, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
May 21, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 16, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 16, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 12, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 12, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 4, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 4, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 4, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 18, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Apr 17, 2023 AMPX
ASSIGNED TO LIE
Apr 14, 2023 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 31, 2023 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 19, 2023 PARI
NEW APPLICATION ENTERED
Jan 12, 2023 NWAP